McCarthy Rebecca L, Tawfik Soha S, Theocharopoulos Ioannis, Atkar Ravinder, McDonald Bryan, Dhoat Sasha, Hughes Aaron, Thomas Bjorn R, O'Toole Edel A
Dermatology Department The Royal London Hospital Barts Health NHS Trust London UK.
Blizard Institute The Faculty of Medicine and Dentistry Queen Mary University of London London UK.
Skin Health Dis. 2024 Mar 12;4(3):e358. doi: 10.1002/ski2.358. eCollection 2024 Jun.
Atopic eczema is a common, chronic, inflammatory skin condition with considerable heterogeneity. South Asian people living in the UK frequently have low serum vitamin D3 (25(OH)D), and those with atopic disease can present with severe eczema. The association between vitamin D deficiency and eczema severity, and the role of vitamin D supplementation in atopic eczema is inconsistent, and under-researched in people with Asian ancestry.
This cross-sectional study investigates the association between serum 25(OH)D and eczema severity in a cohort of South Asian children and young adults living in London.
Eligible participants were Bangladeshi children and young adults aged 0-30 years with eczema, living in London and participating in the Tower Hamlets Eczema Assessment study. Data was collected via parent/patient self-reporting, clinical history and examination, and hospital databases. 25(OH)D levels were documented retrospectively, if available, from hospital databases. Eczema severity was classified by Eczema Area and Severity Index (EASI) score less than or greater than 10 (clear-mild vs. moderate-severe). Multivariate logistic regression was used to adjust for confounding factors.
681 participants were included in analyses. 25(OH)D results were available for 49.6% (338/681), 84.3% of which had deficient or insufficient lowest 25(OH)D. Lowest 25(OH)D was inversely correlated with EASI score (Spearman's rank = -0.24, < 0.001). 26.1% (178/681) had EASI >10 and a lower median lowest and nearest 25(OH)D. After adjustment for confounding EASI > 10 was significantly associated with a lowest 25(OH)D < 25 (OR 3.21, 95%CI 1.35, 8.60), use of mild-moderate potency topical steroid on the face and neck (OR 3.11, 95%CI 1.86, 5.31), calcineurin inhibitor on the face and neck (OR 2.79, 95% CI 1.26, 6.10) and potent - very potent topical steroid on the face and neck (OR2.23, 95%CI 1.02, 4.77) and body (OR 2.11, 95%CI 1.18, 3.87).
Vitamin D plays a role in modulation of proteins required for skin barrier function and regulation of the innate immune system, suggesting 25(OH)D deficiency contributes to skin inflammation. This study demonstrates a relationship between 25(OH)D deficiency and worse eczema severity in a cohort of South Asian children and young adults.
特应性皮炎是一种常见的慢性炎症性皮肤病,具有相当大的异质性。生活在英国的南亚人血清维生素D3(25(OH)D)水平常常较低,而患有特应性疾病的人可能会出现严重的湿疹。维生素D缺乏与湿疹严重程度之间的关联,以及维生素D补充剂在特应性皮炎中的作用并不一致,并且在亚洲血统人群中研究不足。
这项横断面研究调查了居住在伦敦的南亚儿童和年轻人队列中血清25(OH)D与湿疹严重程度之间的关联。
符合条件的参与者为年龄在0至30岁、患有湿疹、居住在伦敦并参与塔哈姆雷特湿疹评估研究的孟加拉儿童和年轻人。数据通过家长/患者自我报告、临床病史和检查以及医院数据库收集。如有可用数据,25(OH)D水平从医院数据库中进行回顾性记录。湿疹严重程度根据湿疹面积和严重程度指数(EASI)评分小于或大于10(轻度与中度 - 重度)进行分类。使用多变量逻辑回归来调整混杂因素。
681名参与者纳入分析。49.6%(338/681)的参与者有25(OH)D结果,其中84.3%的人最低25(OH)D水平不足或缺乏。最低25(OH)D与EASI评分呈负相关(斯皮尔曼等级相关系数 = -0.24,P < 0.001)。26.1%(178/681)的人EASI > 10,其最低和最近的25(OH)D中位数较低。在调整混杂因素后,EASI > 10与最低25(OH)D < 25显著相关(比值比3.21,95%置信区间1.35,8.60),面部和颈部使用中效 - 强效外用类固醇(比值比3.11,95%置信区间1.86,5.31),面部和颈部使用钙调神经磷酸酶抑制剂(比值比2.79,95%置信区间1.26,6.10)以及面部和颈部(比值比2.23,95%置信区间1. O2,4.77)和身体(比值比2.11,95%置信区间1.18,3.87)使用强效 - 超强效外用类固醇。
维生素D在调节皮肤屏障功能所需的蛋白质和先天免疫系统的调节中起作用,这表明25(OH)D缺乏会导致皮肤炎症。这项研究证明了在南亚儿童和年轻人队列中25(OH)D缺乏与更严重的湿疹严重程度之间的关系。